NCT00234689

Completed

Efficacy of Naltrexone Treatment as Augmentation to SSRI in ...

Sheba Medical Center Source

Compare

Other study identifiers

Sponsor study identifier

SHEBA-99-1897-JZ-CTIL

Study Type

interventional

Reported enrollment (type unavailable)

N/A

Locations

1 country

Sites

1

Timeline

Study Start

January 2002

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

December 2004

Actual (reported)

Study Completion

December 2004

Actual (reported)

Brief Summary

Assessing the efficacy of Naltrexone as augmentation to SSRI in patients with OCD

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Reported enrollment (type unavailable): Not reported
Study completion date: December 2004
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
January 2002
Date type not reported
This date has not been verified as actual or estimated.
Primary Completion
December 2004
Actual (reported)
Study Completion
December 2004
Actual (reported)
First Submitted
October 6, 2005
Actual (reported)
First Posted
October 7, 2005
Actual (reported)

Last Updated: January 30, 2008
Status Verified: January 2008
Last Update Submitted: January 28, 2008

Conditions

Obsessive Compulsive Disorder

Interventions

NaltrexoneDrug

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years - 65 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

Diagnosis of OCD
Treatment with SSRI for at least 10 weeks with no response

You may not qualify if:

Sponsors & Collaborators

Sheba Medical Center
Governmentlead

Study Sites (1)

Chaim Sheba Medical Center

Ramat Gan, 52621, Israel

MeSH Terms

Conditions

Obsessive-Compulsive Disorder

Interventions

Naltrexone

Condition Hierarchy (Ancestors)

Anxiety DisordersMental Disorders

Intervention Hierarchy (Ancestors)

NaloxoneMorphinansOpiate AlkaloidsAlkaloidsHeterocyclic CompoundsHeterocyclic Compounds, Bridged-RingHeterocyclic Compounds, 4 or More RingsHeterocyclic Compounds, Fused-Ring

Study Officials

Joseph Zohar, MD
Tel Aviv University
PRINCIPAL INVESTIGATOR
Revital Amiaz, MD
Tel Aviv University
STUDY CHAIR

Study Design

Study Type: interventional
Phase: not applicable
Allocation: RANDOMIZED
Masking: DOUBLE
Intervention Model: CROSSOVER
Sponsor Type: OTHER GOV

Study Record Dates

First Submitted

October 6, 2005

First Posted

October 7, 2005

Study Start

January 2002

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

December 2004

Actual (reported)

NCT00057603

Deep Brain Stimulation for Treatment-Resistant Obsessive Compulsive Disorder

Not ApplicableCompleted

NCT00184262

Exposure and Response Prevention With Behavioral- Versus Cognitive Therapy Rationale in Obsessive Compulsive Disorder

Not ApplicableCompleted

NCT02407288

tDCS as an add-on Treatment in SSRI-resistant OCD

Not ApplicableUnknown

NCT00126282

A Medication Trial Combined With Behavior Therapy for Individuals With Obsessive-compulsive Disorder

Not ApplicableCompleted

NCT00045903

Cognitive Behavioral Therapy Plus Drug Treatment for Obsessive Compulsive Disorder

Not ApplicableCompleted

NCT07116785

Accelerated Rotational Field Deep TMS for Treating OCD

Not ApplicableRecruiting

Suffering from any medical condition
treatment with opiates
chronic use of drugs
Hepatitis or other liver related diseases
Incapability to sign an informed consent

Contact the study team to confirm eligibility.

Phenanthrenes

Polycyclic Aromatic Hydrocarbons

Polycyclic Compounds

Study Completion

December 2004

Actual (reported)

Last Updated

January 30, 2008

Record last verified: 2008-01

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00234689
Data provider: ClinicalTrials.gov
Source updated: 2008-01-30
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:20:40 UTC

Locations

IL(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Intervention Hierarchy (Ancestors)

Study Officials

Study Design

Study Record Dates

Source record

Locations